Vir Biotechnology, Inc. VIR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $241.07M-24.4% | $318.7M+22.0% | $261.29M-69.9% | $867.97M+139% | ||
| $228.75M-66.3% | $678.05M-46.7% | $1.27B-16.5% | $1.52B+601% | ||
| $514.08M-50.7% | $1.04B-34.4% | $1.59B-37.0% | $2.52B+61.2% | ||
| $55.62M-12.0% | $63.18M-34.2% | $96.02M-9.1% | $105.61M+147% | ||
| $16.94M0.0% | $16.94M0.0% | $16.94M0.0% | $16.94M0.0% | ||
| $7.85M-3.3% | $8.12M-64.0% | $22.57M-31.1% | $32.76M-1.6% | ||
| $1B-28.3% | $1.4B-27.1% | $1.92B-31.5% | $2.8B+43.4% | ||
| $32.61M+36.5% | $23.89M-30.7% | $34.47M+12.2% | $30.72M+20.6% | ||
| $92.82M-22.4% | $119.66M-31.8% | $175.41M-65.7% | $511.03M+49.8% | ||
| $237.55M-4.4% | $248.43M-24.4% | $328.82M-54.6% | $724.13M+38.6% | ||
| 300M+2,142,757% | 14K+7.7% | 13K0.0% | 13K0.0% | ||
| -$1.2B-57.6% | -$759.78M-219% | -$237.82M-163% | $377.24M+372% | ||
| $765.28M-33.5% | $1.15B-27.7% | $1.59B-23.5% | $2.08B+45.1% | ||
| $1B-28.3% | $1.4B-27.1% | $1.92B-31.5% | $2.8B+43.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Vir Biotechnology, Inc. cover its short-term obligations?
- Its current ratio is 7.11 — current assets exceed current liabilities.
- Where does Vir Biotechnology, Inc.'s balance sheet data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.